These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34555518)

  • 1. Maintenance Therapy With the Lowest Effective Dose of Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
    Oliva S; Volpe D; Russo G; Veraldi S; Papoff P; Giordano C; Ruggiero C; Trovato CM; Terrin G; Rossetti D
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2905-2907.e2. PubMed ID: 34555518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials.
    Murali AR; Gupta A; Attar BM; Ravi V; Koduru P
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1111-9. PubMed ID: 26699695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic esophagitis: Pathophysiology, diagnosis, and management.
    Vinit C; Dieme A; Courbage S; Dehaine C; Dufeu CM; Jacquemot S; Lajus M; Montigny L; Payen E; Yang DD; Dupont C
    Arch Pediatr; 2019 Apr; 26(3):182-190. PubMed ID: 30827775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of eosinophlic esophagitis with swallowed topical corticosteroids.
    Nennstiel S; Schlag C
    World J Gastroenterol; 2020 Sep; 26(36):5395-5407. PubMed ID: 33024392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic esophagitis--treatment of eosinophilic esophagitis with drugs: corticosteroids.
    von Arnim U; Malfertheiner P
    Dig Dis; 2014; 32(1-2):126-9. PubMed ID: 24603395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent insights on the use of topical steroids in eosinophilic esophagitis.
    Reddy A; Ashat D; Murali AR
    Expert Rev Gastroenterol Hepatol; 2020 Oct; 14(10):953-963. PubMed ID: 32567417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach.
    Munoz-Persy M; Lucendo AJ
    Eur J Pediatr; 2018 May; 177(5):649-663. PubMed ID: 29549437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real-world efficacy from the EoE CONNECT registry.
    Laserna-Mendieta EJ; Navarro P; Casabona-Francés S; Savarino EV; Amorena E; Pérez-Martínez I; Guagnozzi D; Blas-Jhon L; Betoré E; Guardiola-Arévalo A; Pellegatta G; Krarup AL; Perello A; Barrio J; Gutiérrez-Junquera C; Teruel Sánchez-Vegazo C; Fernández-Fernández S; Naves JE; Oliva S; Rodríguez-Oballe JA; Carrión S; Espina S; Llorente Barrio M; Masiques-Mas ML; Dainese R; Feo-Ortega S; Martín-Dominguez V; Fernández-Pacheco J; Pérez-Fernández MT; Ghisa M; Maniero D; Nantes-Castillejo Ó; Nicolay-Maneru J; Suárez A; Maray I; Llerena-Castro R; Ortega-Larrodé A; Alcedo J; Granja Navacerrada A; Racca F; Santander C; Arias Á; Lucendo AJ;
    United European Gastroenterol J; 2024 Jun; 12(5):585-595. PubMed ID: 38284792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-Week Maintenance Therapy with a New Prepared Viscous Budesonide in Pediatric Eosinophilic Esophagitis.
    Oliva S; Rossetti D; Papoff P; Tiberti A; Mallardo S; Volpe D; Ruggiero C; Russo G; Vezzoli D; Isoldi S; Cucchiara S
    Dig Dis Sci; 2019 Jun; 64(6):1571-1578. PubMed ID: 30659470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Viscous Budesonide in Children With Eosinophilic Esophagitis After Repaired Esophageal Atresia: A Clinical Trial.
    Tambucci R; Roversi M; Rea F; Malamisura M; Angelino G; Biondi I; Simeoli R; Goffredo BM; Francalanci P; Simonetti A; Livadiotti S; Corsetti T; Dall'Oglio L; Rossi P; Pontrelli G; De Angelis P
    J Pediatr Gastroenterol Nutr; 2023 Aug; 77(2):249-255. PubMed ID: 37195886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swallowed topical steroid therapy for eosinophilic oesophagitis in children: practical, evidence-based guidance by the BSPGHAN Eosinophilic Oesophagitis Working Group.
    Chan J; Flynn DM; Gordon M; Parmar R; Moolenschot K; Jackman L; Gaynor E; Epstein J; Cordell A; Kannappan H; Furman M; Thompson J; Gasparetto M; Auth MKH
    BMJ Paediatr Open; 2024 May; 8(1):. PubMed ID: 38782481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and Therapeutic Long-term Management of Eosinophilic Esophagitis- Current Concepts and Perspectives for Steroid Use.
    Greuter T; Alexander JA; Straumann A; Katzka DA
    Clin Transl Gastroenterol; 2018 Dec; 9(12):e212. PubMed ID: 30802222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.
    Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ
    Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.
    Straumann A; Conus S; Degen L; Frei C; Bussmann C; Beglinger C; Schoepfer A; Simon HU
    Clin Gastroenterol Hepatol; 2011 May; 9(5):400-9.e1. PubMed ID: 21277394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Viscous Budesonide Formulation for the Treatment of Eosinophilic Esophagitis in Children: A Preliminary Experience and Review of the Literature.
    Warzecha J; Dziekiewicz M; Bieńkowska-Tokarczyk A; Małecki M; Banaszkiewicz A
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
    Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
    Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel corticosteroid formulations in the treatment of eosinophilic esophagitis: what is the evidence?
    Walgraeve S; Vanuytsel T
    Acta Gastroenterol Belg; 2023; 86(3):437-448. PubMed ID: 37814560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic Esophagitis: Impact of Latest Insights Into Pathophysiology on Therapeutic Strategies.
    Schoepfer A; Safroneeva E; Straumann A
    Dig Dis; 2016; 34(5):462-8. PubMed ID: 27333298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia.
    Chan LJ; Tan L; Dhaliwal J; Briglia F; Clarkson C; Krishnan U
    Dis Esophagus; 2016 Aug; 29(6):563-71. PubMed ID: 25872589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic esophagitis: short and long-term considerations.
    Goyal A
    Curr Opin Pediatr; 2018 Oct; 30(5):646-652. PubMed ID: 30015687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.